Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients-Reference-Cited by-同舟云学术

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients

Published:2004-03 Issue:5 Volume:18 Page:775-779
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Hicks Charles,King Martin S,Gulick Roy M,White Jr A Clinton,Eron Jr Joseph J,Kessler Harold A,Benson Constance,King Kathryn R,Murphy Robert L,Brun Scott C

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference9 articles.

1. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

2. Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease

3. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

4. ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

5. Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trial protocols of repurposed prophylaxis for COVID-19: A review;Infectious Diseases Now;2021-02

2. Comparative outcomes of lopinavir/ritonavir and hydroxychloroquine for the treatment of COVID-19 with mild-to-moderate severity: A retrospective observational study;Antiviral Therapy;2021-01

3. Early risk factors of the exacerbation of coronavirus disease 2019 pneumonia;Journal of Medical Virology;2020-08-21

4. Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19;British Journal of Clinical Pharmacology;2020-08-03

5. In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses;The Korean Journal of Internal Medicine;2020-07-01